FDA Adds Boxed Warning to Canagliflozin for Amputation Risk http://www.medscape.com/viewarticle/880059 The US Food and Drug Administration (FDA) has issued a new boxed warning to the label of canagliflozin (Invokana, Invokamet, Janssen) to describe the risk for leg and foot amputations. This heightened warning follows a May 2016 safety alert based on interim data from one […]
Filed under: General Problems | Leave a Comment »